Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 24 01:30PM ET
23.89
Dollar change
0.00
Percentage change
0.00
%
CategoryUS Equities - Factor & Thematic Asset TypeEquities (Stocks) TagsDeveloped Return% 1Y- Shs Outstand Perf Week-3.80%
SponsorF/m Investments ETF Type Tagsequity Return% 3Y- Total Holdings32 Perf Month-6.93%
Fund Family Bond Type Tagsinnovation Return% 5Y- AUM49.62M Perf Quarter-
Index- Average Maturity Tagshealthcare Return% 10Y NAV% Perf Half Y-
Index Weighting Commodity Type Tagsbiotechnology Return% SI NAV/sh Perf Year-
Active/Passive Quant Type Tagsmedical Flows% 1M-0.12% 52W Range23.46 - 27.76 Perf YTD-4.01%
Dividend TTM- ESG Type Tagspharmaceutical Flows% 3M4.27% 52W High-13.94% Beta-
Dividend Ex-Date- Dividend Type Sector/Theme Flows% YTD4.27% 52W Low1.84% ATR (14)0.42
Expense0.79% Structure Type Region Flows% 1Y RSI (14)39.80 Volatility0.78% 0.57%
Option/ShortNo / No Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.00 Prev Close23.89
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume3.11K Price23.89
SMA20-5.21% SMA50-6.25% SMA200-6.25% Trades Volume0 Change0.00%
F/m Emerald Life Sciences Innovation ETF seeks long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") and invests primarily in equity securities of life science companies selected by Emerald Mutual Fund Advisers Trust, the fund's investment sub-adviser, under the supervision of the adviser. Under normal market conditions, the fund invests at least 80% of its net assets in equity securities issued by life science companies demonstrating innovation.